Your browser doesn't support javascript.
loading
[Endocrine disruptors and obesity: obesogens]. / Disruptores endocrinos y obesidad: obesógenos.
García-Mayor, Ricardo V; Larrañaga Vidal, Alejandra; Docet Caamaño, Maria F; Lafuente Giménez, Anunciación.
Afiliação
  • García-Mayor RV; Unidad de Investigación Compartida «Obesógenos¼ Sergas, Servicio de Endocrinología, Diabetes, Nutrición y Metabolismo, Universidad de Vigo, Vigo, España. ricardo.garcia.mayor@sergas.es
Endocrinol Nutr ; 59(4): 261-7, 2012 Apr.
Article em Es | MEDLINE | ID: mdl-22300604
ABSTRACT
Incidence and prevalence of owerweight and obesity have greatly increased over the past three decades in almost all countries around the world. This phenomenon is not easily explained by lifestyle changes in populations with very different initial habits. This has led to consider the influence of other factors, the so-called endocrine disruptors, and more specifically obesogens. This study reviewed the available evidence about polluting chemical substances which may potentially be obesogens in humans DES, genistein, bisphenol A, organotins (TBT, TPT), and phthalates. The first three groups of substances mainly act upon estrogen receptors, while organotins and phthalates activate PPARγ. It was concluded that evidence exists of the obesogenic effect of these chemical substances in tissues and experimental animals, but few data are available in humans.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disruptores Endócrinos / Obesidade Idioma: Es Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disruptores Endócrinos / Obesidade Idioma: Es Ano de publicação: 2012 Tipo de documento: Article